Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D.

Nat Med. 2012 Jun;18(6):883-91. doi: 10.1038/nm.2753.

PMID:
22635005
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Myeloma as a model for the process of metastasis: implications for therapy.

Ghobrial IM.

Blood. 2012 Jul 5;120(1):20-30. doi: 10.1182/blood-2012-01-379024. Epub 2012 Apr 24.

PMID:
22535658
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Angiogenesis and multiple myeloma.

Giuliani N, Storti P, Bolzoni M, Palma BD, Bonomini S.

Cancer Microenviron. 2011 Dec;4(3):325-37. doi: 10.1007/s12307-011-0072-9. Epub 2011 Jul 7.

PMID:
21735169
[PubMed]
Free PMC Article
4.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.

Korde N, Kristinsson SY, Landgren O.

Blood. 2011 May 26;117(21):5573-81. doi: 10.1182/blood-2011-01-270140. Epub 2011 Mar 25. Review.

PMID:
21441462
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Dinarello CA.

Blood. 2011 Apr 7;117(14):3720-32. doi: 10.1182/blood-2010-07-273417. Epub 2011 Feb 8. Review.

PMID:
21304099
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M; International Myeloma Working Group.

Leukemia. 2010 Jun;24(6):1121-7. doi: 10.1038/leu.2010.60. Epub 2010 Apr 22. Review.

PMID:
20410922
[PubMed - indexed for MEDLINE]
7.

IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms.

De Bruyne E, Bos TJ, Schuit F, Van Valckenborgh E, Menu E, Thorrez L, Atadja P, Jernberg-Wiklund H, Vanderkerken K.

Blood. 2010 Mar 25;115(12):2430-40. doi: 10.1182/blood-2009-07-232801. Epub 2010 Jan 19.

PMID:
20086250
[PubMed - indexed for MEDLINE]
Free Article
8.

Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.

Ria R, Todoerti K, Berardi S, Coluccia AM, De Luisi A, Mattioli M, Ronchetti D, Morabito F, Guarini A, Petrucci MT, Dammacco F, Ribatti D, Neri A, Vacca A.

Clin Cancer Res. 2009 Sep 1;15(17):5369-78. doi: 10.1158/1078-0432.CCR-09-0040. Epub 2009 Aug 18.

PMID:
19690192
[PubMed - indexed for MEDLINE]
Free Article
9.

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.

Fulciniti M, Tassone P, Hideshima T, Vallet S, Nanjappa P, Ettenberg SA, Shen Z, Patel N, Tai YT, Chauhan D, Mitsiades C, Prabhala R, Raje N, Anderson KC, Stover DR, Munshi NC.

Blood. 2009 Jul 9;114(2):371-9. doi: 10.1182/blood-2008-11-191577. Epub 2009 May 5.

PMID:
19417213
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The metastatic niche: adapting the foreign soil.

Psaila B, Lyden D.

Nat Rev Cancer. 2009 Apr;9(4):285-93. doi: 10.1038/nrc2621.

PMID:
19308068
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A monoclonal gammopathy precedes multiple myeloma in most patients.

Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM.

Blood. 2009 May 28;113(22):5418-22. doi: 10.1182/blood-2008-12-195008. Epub 2009 Feb 20.

PMID:
19234139
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.

Lust JA, Lacy MQ, Zeldenrust SR, Dispenzieri A, Gertz MA, Witzig TE, Kumar S, Hayman SR, Russell SJ, Buadi FK, Geyer SM, Campbell ME, Kyle RA, Rajkumar SV, Greipp PR, Kline MP, Xiong Y, Moon-Tasson LL, Donovan KA.

Mayo Clin Proc. 2009 Feb;84(2):114-22. doi: 10.4065/84.2.114.

PMID:
19181644
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV.

Blood. 2009 May 28;113(22):5412-7. doi: 10.1182/blood-2008-12-194241. Epub 2009 Jan 29.

PMID:
19179464
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pathogenesis of myeloma bone disease.

Roodman GD.

Leukemia. 2009 Mar;23(3):435-41. doi: 10.1038/leu.2008.336. Epub 2008 Nov 27. Review.

PMID:
19039321
[PubMed - indexed for MEDLINE]
15.

Insulin and insulin-like growth factor signalling in neoplasia.

Pollak M.

Nat Rev Cancer. 2008 Dec;8(12):915-28. doi: 10.1038/nrc2536. Review. Erratum in: Nat Rev Cancer. 2009 Mar;9(3):224.

PMID:
19029956
[PubMed - indexed for MEDLINE]
16.

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.

Kyle RA, Rajkumar SV.

Leukemia. 2009 Jan;23(1):3-9. doi: 10.1038/leu.2008.291. Epub 2008 Oct 30. Review. Erratum in: Leukemia. 2014 Apr;28(4):980.

PMID:
18971951
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.

Edwards CM, Edwards JR, Lwin ST, Esparza J, Oyajobi BO, McCluskey B, Munoz S, Grubbs B, Mundy GR.

Blood. 2008 Mar 1;111(5):2833-42. Epub 2007 Dec 19.

PMID:
18094333
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets.

Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC.

Nat Rev Cancer. 2007 Aug;7(8):585-98. Review.

PMID:
17646864
[PubMed - indexed for MEDLINE]
19.

Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.

Tanaka Y, Abe M, Hiasa M, Oda A, Amou H, Nakano A, Takeuchi K, Kitazoe K, Kido S, Inoue D, Moriyama K, Hashimoto T, Ozaki S, Matsumoto T.

Clin Cancer Res. 2007 Feb 1;13(3):816-23.

PMID:
17289872
[PubMed - indexed for MEDLINE]
Free Article
20.

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM, Jia X, Lu G, Timm M, Kumar A, Côté D, Veilleux I, Hedin KE, Roodman GD, Witzig TE, Kung AL, Hideshima T, Anderson KC, Lin CP, Ghobrial IM.

Blood. 2007 Apr 1;109(7):2708-17.

PMID:
17119115
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk